RNA cleavage-induced transcript stabilizer and uses thereof
US-11795455-B2 · Oct 24, 2023 · US
US12480119B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12480119-B2 |
| Application number | US-202318466891-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 14, 2023 |
| Priority date | Jul 31, 2017 |
| Publication date | Nov 25, 2025 |
| Grant date | Nov 25, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are genetic circuits and encoded RNA transcripts that produce an output molecule in response to an RNA cleavage event that removes a degradation signal. In some embodiments, the genetic circuits described herein may be used for detecting RNA cleaver activities (e.g., in a cell). Methods of using the genetic circuits described herein in diagnostic or therapeutic applications are also provided.
Opening claim text (preview).
What is claimed is: 1 . A cleavage-induced transcript stabilizer comprising: (i) an RNA transcript comprising a ribonucleotide sequence encoding an output molecule followed, in order, by: an RNA stabilizer, a cleavage site for an RNA cleaver, and a degradation signal that leads to degradation of the RNA transcript; wherein the RNA cleaver is an endoribonuclease, a siRNA, a miRNA, or a ribozyme; and wherein the cleavage-induced transcript stabilizer comprises one or more recognition sites for an RNA repressor operably linked to the nucleotide sequence encoding the output molecule. 2 . The cleavage-induced transcript stabilizer of claim 1 , further comprising: (ii) a promoter operably linked to a nucleotide sequence encoding an RNA cleaver that cleaves the RNA transcript at the cleavage site. 3 . The cleavage-induced transcript stabilizer of claim 2 , wherein the promoter of (ii) is an inducible promoter. 4 . The cleavage-induced transcript stabilizer of claim 1 , wherein the RNA transcript is degraded in the absence of the RNA cleaver. 5 . The cleavage-induced transcript stabilizer of claim 1 , wherein the RNA transcript is expressed in the presence of the RNA cleaver. 6 . The cleavage-induced transcript stabilizer of claim 5 , wherein the cleavage of the RNA transcript stabilizes the RNA transcript and results in expression of the output molecule. 7 . The cleavage-induced transcript stabilizer of claim 1 , wherein the output molecule is a detectable molecule. 8 . The cleavage-induced transcript stabilizer of claim 1 , wherein the output molecule is a therapeutic molecule. 9 . The cleavage-induced transcript stabilizer of claim 1 , wherein the output molecule is a functional molecule. 10 . The cleavage-induced transcript stabilizer of claim 9 , wherein the functional molecule is selected from the group consisting of: TetR, CNOT7, DDX6, PPR10, L7Ae, Csy4, Cas6, CasE, and Cse3. 11 . An isolated cell comprising the cleavage-induced transcript stabilizer of claim 1 . 12 . The isolated cell of claim 11 , wherein a genetic circuit that encodes the cleavage-induced transcript stabilizer is inserted into the genome of the cell. 13 . A method comprising maintaining the isolated cell of claim 11 . 14 . A method comprising delivering the cleavage-induced transcript stabilizer of claim 1 to a cell and detecting the output molecule. 15 . A method of detecting an RNA cleaver activity, comprising: delivering the cleavage-induced transcript stabilizer of claim 1 to a cell and detecting the output molecule. 16 . A method of treating a disease or disorder comprising delivering the cleavage-induced transcript stabilizer of claim 1 to a cell, wherein the output molecule is a therapeutic molecule that is effective for treating the disease or disorder. 17 . A method of diagnosing a disease or disorder comprising delivering the cleavage-induced transcript stabilizer of claim 1 to a cell and detecting the output molecule. 18 . A method of treating a disease or disorder comprising administering an effective amount of a composition comprising the cleavage-induced transcript stabilizer of claim 1 to a subject in need thereof, wherein the output molecule is a therapeutic molecule that is effective for treating the disease or disorder. 19 . A method of diagnosing a disease or disorder comprising administering an effective amount of a composition comprising the cleavage-induced transcript stabilizer of claim 1 to a subject in need thereof and detecting the output molecule.
General methods for enhancing the expression · CPC title
enhancing translation · CPC title
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title
Hairpin · CPC title
involving RNAse P · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.